• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Neuropace, Inc. - Common Stock (NQ:NPCE)

    13.38 +0.38 (+2.92%)
    Official Closing Price Updated: 4:15 PM EDT, Mar 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 237,028
    Open 13.46
    Bid (Size) 13.11 (300)
    Ask (Size) 15.12 (100)
    Prev. Close 13.00
    Today's Range 13.07 - 13.64
    52wk Range 7.562 - 18.98
    Shares Outstanding 24,296,259
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    NeuroPace to Present at the Leerink Global Healthcare Conference
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    Why NeuroPace Stock Was Inching Higher on Wednesday ↗
    The company finished 2025 with a convincing pair of earnings beats. 
    Via The Motley Fool

    Performance

    YTD
    -11.8%
    -11.8%
    1 Month
    -6.7%
    -6.7%
    3 Month
    -19.2%
    -19.2%
    6 Month
    +29.2%
    +29.2%
    1 Year
    +8.8%
    +8.8%

    More News

    Read More
    News headline image
    NeuroPace (NPCE) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    NeuroPace Inc (NASDAQ:NPCE) Beats Q4 2025 Estimates and Reiterates 2026 Outlook ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace (NPCE) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings World Trade
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
    Via MarketMinute
    Topics Earnings Supply Chain
    News headline image
    NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
    From NeuroPace, Inc.
    Via Business Wire
    News headline image
    NeuroPace to Participate in Upcoming Healthcare Conferences
    From NeuroPace, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Neuropace, Inc. - Common Stock publicly traded?
    Yes, Neuropace, Inc. - Common Stock is publicly traded.
    What exchange does Neuropace, Inc. - Common Stock trade on?
    Neuropace, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Neuropace, Inc. - Common Stock?
    The ticker symbol for Neuropace, Inc. - Common Stock is NPCE on the Nasdaq Stock Market
    What is the current price of Neuropace, Inc. - Common Stock?
    The current price of Neuropace, Inc. - Common Stock is 13.38
    When was Neuropace, Inc. - Common Stock last traded?
    The last trade of Neuropace, Inc. - Common Stock was at 03/23/26 04:15 PM ET
    What is the market capitalization of Neuropace, Inc. - Common Stock?
    The market capitalization of Neuropace, Inc. - Common Stock is 325.08M
    How many shares of Neuropace, Inc. - Common Stock are outstanding?
    Neuropace, Inc. - Common Stock has 325M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.